Metronomic cyclophosphamide appears safe and potentially effective in older, frail patients with metastatic cancer, supporting its use as an alternative to supportive care in late disease stages.
Does metronomic cyclophosphamide provide a safe and effective treatment option in older and frail patients with metastatic cancer?
Metronomic cyclophosphamide may serve as a pragmatic alternative to supportive care in older, frail patients with metastatic cancer.
Absolute Event Rate: 0% vs 0%
Metronomic cyclophosphamide appears to be a safe and potentially effective option in older and frail patients with metastatic cancer, including those with limited functional reserve. These findings support its use as a pragmatic alternative to supportive care, even in late disease stages.
Griffe et al. (Sat,) reported a other. Metronomic cyclophosphamide appears safe and potentially effective in older, frail patients with metastatic cancer, supporting its use as an alternative to supportive care in late disease stages.